Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Effects of a 90-min educational intervention for patients with insect venom allergy: a prospective controlled pilot study.

Tytuł:
Effects of a 90-min educational intervention for patients with insect venom allergy: a prospective controlled pilot study.
Autorzy:
Schoeben LS; Department of Dermatology, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Germany.
Mohr N; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bubak C; Department of Dermatology, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Germany.
Schmieder A; Department of Dermatology, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Germany.
Schaarschmidt ML; Department of Dermatology, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Germany. .
Źródło:
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology [Allergy Asthma Clin Immunol] 2021 Feb 25; Vol. 17 (1), pp. 22. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: Oct. 2009- : London : BioMed Central
Original Publication: Hamilton, Ont. : BC Decker, c2004-
References:
Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J, et al. Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB). Allergo J Int. 2014;23:96–112. (PMID: 10.1007/s40629-014-0009-1)
Confino-Cohen R, Melamed S, Goldberg A. Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergy. Clin Exp Allergy. 1999;29:1626–31. (PMID: 10.1046/j.1365-2222.1999.00656.x)
Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353–61. (PMID: 10.1111/all.12272)
Turner PJ, Campbell DE, Motosue MS, Campbell RL. Global Trends in Anaphylaxis Epidemiology and Clinical Implications. J Allergy Clin Immunol Pract. 2020;8:1169–76. (PMID: 10.1016/j.jaip.2019.11.027)
Antonicelli L, Bilo MB, Bonifazi F. Epidemiology of Hymenoptera allergy. Curr Opin Allergy Clin Immunol. 2002;2:341–6. (PMID: 10.1097/00130832-200208000-00008)
Golden DB, Breisch NL, Hamilton RG, Guralnick MW, Greene A, Craig TJ, et al. Clinical and entomological factors influence the outcome of sting challenge studies. J Allergy Clin Immunol. 2006;117:670–5. (PMID: 10.1016/j.jaci.2005.12.1313)
Dhami S, Zaman H, Varga EM, Sturm GJ, Muraro A, Akdis CA, et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy. 2017;72:342–65. (PMID: 10.1111/all.13077)
Oude Elberink JN, van der Heide S, Guyatt GH, Dubois AE. Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. J Allergy Clin Immunol. 2006;118:699–704. (PMID: 10.1016/j.jaci.2006.03.049)
Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy. 2003;33(8):1033–40. (PMID: 10.1046/j.1365-2222.2003.01671.x)
Goldberg A, Confino-Cohen R. Insect sting-inflicted systemic reactions: attitudes of patients with insect venom allergy regarding after-sting behavior and proper administration of epinephrine. J Allergy Clin Immunol. 2000;106:1184–9. (PMID: 10.1067/mai.2000.110927)
Huang S-W. A survey of Epi-PEN use in patients with a history of anaphylaxis. Journal of Allergy and Clinical Immunology. 1998;102:525–6. (PMID: 10.1016/S0091-6749(98)70145-9)
Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol. 2000;106(1 Pt 1):171–6. (PMID: 10.1067/mai.2000.106041)
Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30:1144–50. (PMID: 10.1046/j.1365-2222.2000.00864.x)
Sanchez J. How often patients carry epinephrine in real life? Anaphylaxis. 2013;60(4):168–71.
Worm M, Eckermann O, Dolle S, Aberer W, Beyer K, Hawranek T, et al. Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany. Austria and Switzerland Dtsch Arztebl Int. 2014;111:367–75. (PMID: 24939374)
Cohen MB, Saunders SS, Wise SK, Nassif S, Platt MP. Pitfalls in the use of epinephrine for anaphylaxis: patient and provider opportunities for improvement. Int Forum Allergy Rhinol. 2017;7:276–86. (PMID: 10.1002/alr.21884)
Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N, et al. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy. 2015;70:227–35. (PMID: 10.1111/all.12548)
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70. (PMID: 10.1111/j.1600-0447.1983.tb09716.x)
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res. 2002;52:69–77. (PMID: 10.1016/S0022-3999(01)00296-3)
Mueller HL. Diagnosis and Treatment of Insect Sensitivity. J Asthma Res. 1966;3:331–3. (PMID: 10.3109/02770906609106941)
Schaarschmidt M-L, Gutknecht M, Schoeben L, Schmieder A. Disease burden, psychological well-being and attitudes regarding the set of emergency medication in adults with insect venom allergy. Int Arch Allergy Immunol. 2018;176:150–6. (PMID: 10.1159/000488721)
Schoeben LS, Bubak C, Schaarschmidt ML, Schmieder A. Sex differences in adults with insect venom allergy regarding psychological distress, attitudes toward the emergency medication, and factual knowledge about the disease. Int Arch Allergy Immunol. 2020;181:529–35. (PMID: 10.1159/000507625)
Warren CM, Zaslavsky JM, Kan K, Spergel JM, Gupta RS. Epinephrine auto-injector carriage and use practices among US children, adolescents, and adults. Ann Allergy Asthma Immunol. 2018;9:89.
Golden DB. Anaphylaxis to insect stings. Immunol Allergy Clin North Am. 2015;35:287–302. (PMID: 10.1016/j.iac.2015.01.007)
Kastner M, Harada L, Waserman S. Gaps in anaphylaxis management at the level of physicians, patients, and the community: a systematic review of the literature. Allergy. 2010;65:435–44. (PMID: 10.1111/j.1398-9995.2009.02294.x)
Fethney J. Statistical and clinical significance, and how to use confidence intervals to help interpret both. J Aust Crit Care. 2010;23:93–7. (PMID: 10.1016/j.aucc.2010.03.001)
Bilò MB, Cichocka-Jarosz E, Pumphrey R, Oude-Elberink JN, Lange J, Jakob T, et al. Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement. Allergy. 2016;71:931–43. (PMID: 10.1111/all.12908)
Przybilla B, Ruëff F, Walker A, Räwer HC, Aberer W, Bauer CP, et al. Diagnose und Therapie der Bienen und Wespengiftallergie. Allergo J. 2011;20:318–39. (PMID: 10.1007/BF03362543)
Braddock CH 3rd. The emerging importance and relevance of shared decision making to clinical practice. Med Decis Making. 2010;30(Suppl 5):5–7. (PMID: 10.1177/0272989X10381344)
Deccache A, Aujoulat I. A European perspective: common developments, differences and challenges in patient education. Patient Educ Couns. 2001;44:7–14. (PMID: 10.1016/S0738-3991(01)00096-9)
Barry CA, Bradley CP, Britten N, Stevenson FA, Barber N. Patients’ unvoiced agendas in general practice consultations: qualitative study. BMJ. 2000;320:1246–50. (PMID: 10.1136/bmj.320.7244.1246)
Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ. 2000;320:484–8. (PMID: 10.1136/bmj.320.7233.484)
Williams LM, Alderman JE, Cussell G, Goldston J, Hamilton N, Lim AC, et al. Patient’s self-evaluation of two education programs for age-related skin changes in the face: a prospective, randomized, controlled study. Clin Cosmet Investig Dermatol. 2011;4:149–59. (PMID: 10.2147/CCID.S23329)
Bron MS, O’Neill J, Fogel I. Improving adherence to sertraline treatment: the effectiveness of a patient education intervention. Prim Care Companion J Clin Psychiatry. 2006;8:285–90. (PMID: 10.4088/PCC.v08n0505)
See JA, Goh CL, Hayashi N, Suh DH, Casintahan FA. Optimizing the use of topical retinoids in Asian acne patients. J Dermatol. 2018;45:522–8. (PMID: 10.1111/1346-8138.14314)
Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ. 2006;332:933–8. (PMID: 10.1136/bmj.332.7547.933)
Szczepanski R, Jaeschke R, Spindler T, Ihorst G, Forster J. Preschoolers’ and parents’ asthma education trial (P2AET)–a randomized controlled study. Eur J Pediatr. 2010;169:1051–60. (PMID: 10.1007/s00431-010-1173-z)
Contributed Indexing:
Keywords: Anaphylaxis; Emergency management; Emergency medication; Insect venom allergy; Patient education
Entry Date(s):
Date Created: 20210226 Latest Revision: 20210411
Update Code:
20240105
PubMed Central ID:
PMC7905619
DOI:
10.1186/s13223-021-00524-7
PMID:
33632327
Czasopismo naukowe
Background: Anaphylactic sting reactions need a prompt management. A structured educational intervention for patients with insect sting allergy has not been implemented so far. The purpose of this study was to analyze the effects of a structured 90-min educational intervention for patients with insect sting allergy.
Methods: Patients with an insect venom allergy were offered to participate in a structured 90-min group education (intervention group (IG)) or to attend a control group (CG). The patients' subjective self-assurance in using the emergency medication, the willingness to always carry the emergency medication, the mental health status, absolute one-time willingness-to-pay (WTP) for complete cure, a disease knowledge assessment and a simulation test to examine the ability to manage an acute sting reaction were estimated at baseline (t0) and at follow-up (t1) as outcome parameters.
Results: 55 patients participated in the IG (n = 25, 52.0% female, mean age 55.9 years) or the CG (n = 30, 56.7% female, mean age 52.0 years). Both arms showed a significant gain in self-assurance in using the emergency medication (IG: 6.1 at t0 vs. 8.6 at t1, p < 0.0001 and CG: 7.1 vs. 8.0, p = 0.0062) and ability to manage an acute sting reaction (IG: 6.7 vs. 11.4, p < 0.0001 and CG: 9.0 vs. 10.5, p = 0.0002) at t1. However, trained participants showed a significantly higher gain in the respective parameters. There were no significant changes regarding the remaining examined outcome parameters.
Conclusions: Patients who are willing to invest 90 min in a patient education intervention benefit significantly by an increased subjective and objective empowerment to manage an acute sting reaction.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies